[go: up one dir, main page]

JP2001512458A - 4−アミノエトキシインダゾール誘導体 - Google Patents

4−アミノエトキシインダゾール誘導体

Info

Publication number
JP2001512458A
JP2001512458A JP53584198A JP53584198A JP2001512458A JP 2001512458 A JP2001512458 A JP 2001512458A JP 53584198 A JP53584198 A JP 53584198A JP 53584198 A JP53584198 A JP 53584198A JP 2001512458 A JP2001512458 A JP 2001512458A
Authority
JP
Japan
Prior art keywords
acid
pharmaceutically acceptable
halogen
phenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP53584198A
Other languages
English (en)
Japanese (ja)
Inventor
ミューショー,リチャード・エリック
フェルウェイス,アントニー・ヨハン
Original Assignee
アメリカン・ホーム・プロダクツ・コーポレイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アメリカン・ホーム・プロダクツ・コーポレイション filed Critical アメリカン・ホーム・プロダクツ・コーポレイション
Publication of JP2001512458A publication Critical patent/JP2001512458A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP53584198A 1997-02-18 1998-02-13 4−アミノエトキシインダゾール誘導体 Pending JP2001512458A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80132597A 1997-02-18 1997-02-18
US08/801,325 1997-02-18
PCT/US1998/002413 WO1998035943A1 (en) 1997-02-18 1998-02-13 4-aminoethoxyindazole derivatives

Publications (1)

Publication Number Publication Date
JP2001512458A true JP2001512458A (ja) 2001-08-21

Family

ID=25180801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53584198A Pending JP2001512458A (ja) 1997-02-18 1998-02-13 4−アミノエトキシインダゾール誘導体

Country Status (11)

Country Link
EP (1) EP0960101A1 (es)
JP (1) JP2001512458A (es)
KR (1) KR20000071125A (es)
CN (1) CN1248246A (es)
AR (1) AR011137A1 (es)
AU (2) AU6246198A (es)
BR (1) BR9807397A (es)
CA (1) CA2278746A1 (es)
IL (1) IL131159A0 (es)
WO (2) WO1998035942A1 (es)
ZA (1) ZA981307B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4093588B2 (ja) * 2004-05-26 2008-06-04 ファイザー・インク 新規インダゾール及びインドロン誘導体及び調合剤としてのそれらの使用
KR102602947B1 (ko) * 2014-11-03 2023-11-16 아이오메트 파마 엘티디 제약 화합물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9305623D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents
GB9305641D0 (en) * 1993-03-18 1993-05-05 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
CA2278746A1 (en) 1998-08-20
KR20000071125A (ko) 2000-11-25
IL131159A0 (en) 2001-01-28
WO1998035942A1 (en) 1998-08-20
EP0960101A1 (en) 1999-12-01
AR011137A1 (es) 2000-08-02
CN1248246A (zh) 2000-03-22
ZA981307B (en) 1999-08-17
AU6273398A (en) 1998-09-08
BR9807397A (pt) 2000-03-14
WO1998035943A1 (en) 1998-08-20
AU6246198A (en) 1998-09-08

Similar Documents

Publication Publication Date Title
JPH11509197A (ja) ベンゾ[g]キノリン誘導体
JPH05279357A (ja) アザヘテロサイクリルメチル−クロマン類
JP2001518504A (ja) 5ht4作動薬および拮抗薬
JPH08508289A (ja) 抗精神病ベンゾイミダゾール誘導体
CA2107223C (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
JP2000516936A (ja) ドパミンd2作動薬としておよび5―ht1aリガンドとしての4―アミノエトキシインドール
WO2000061558A1 (en) Remedies for neuropathic pain
JPH06511239A (ja) ヘテロアルコキシベンズアゼピン類
JPH08510221A (ja) Ampa拮抗薬およびそれを用いての治療方法
JP3377227B2 (ja) あるメタノ架橋キノリジン類のアミド類似体類の誘導体類
JPH11502230A (ja) インダゾールカルボキサミド類
JPWO2002096875A1 (ja) 鎮痛作用を有する4−ヒドロキシピペリジン誘導体
JP2974351B2 (ja) プロドラッグとしての6―クロロ―7,8―ジヒドロキシ―1―(4’―ヒドロキシフェニル)―2,3,4,5―テトラヒドロ―1h―3―ベンズアゼピンのカルバメート
JP2001512458A (ja) 4−アミノエトキシインダゾール誘導体
JP2000516959A (ja) 4―アミノエトキシインドロン誘導体
EP0879234A1 (de) 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine als das zentralnervensystem beeinflussende mittel
CN109111439B (zh) 一种酰胺类化合物及包含该化合物的组合物及其用途
WO2006121104A1 (ja) ピペリジン環を有するインドール誘導体の結晶およびその製法
AU2003251974B2 (en) Novel salt and polymorphs of desloratadine hemifumarate
JP2000509730A (ja) キノキサリンジオン類
JPH09169764A (ja) 2−(アミノメチル)−3,4,7,9−テトラヒドロ−2H−ピラノ[2,3−e]インドール−8−オンおよびその誘導体
PH27084A (en) Agents for the treatment of acute and chronic obstructive respiratory passage diseases
US5756521A (en) Chroman-2-ylmethylamino derivatives
US5872144A (en) 4-aminoethoxyindazole derivatives
EP1424334B1 (en) Quinazolinone derivative